T, S., M, K., & Y, K. (2024). ASO Author Reflections: Evaluating NPTXR as a Prognostic Biomarker and Therapeutic Target in Esophageal Squamous Cell Carcinoma. Annals of surgical oncology, 31(9), 5765. https://doi.org/10.1245/s10434-024-15425-3
Chicago Style (17th ed.) CitationT, Shinozuka, Kanda M, and Kodera Y. "ASO Author Reflections: Evaluating NPTXR as a Prognostic Biomarker and Therapeutic Target in Esophageal Squamous Cell Carcinoma." Annals of Surgical Oncology 31, no. 9 (2024): 5765. https://doi.org/10.1245/s10434-024-15425-3.
MLA (9th ed.) CitationT, Shinozuka, et al. "ASO Author Reflections: Evaluating NPTXR as a Prognostic Biomarker and Therapeutic Target in Esophageal Squamous Cell Carcinoma." Annals of Surgical Oncology, vol. 31, no. 9, 2024, p. 5765, https://doi.org/10.1245/s10434-024-15425-3.